| 000 | 04916cam a2200481Ii 4500 | ||
|---|---|---|---|
| 988 | _aSpringer_Medicine_2017 | ||
| 999 |
_c94530 _d94530 _x1 |
||
| 001 | 94530 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230102112617.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||unuuu | ||
| 008 | 160831t20162017ja a ob 001 0 eng d | ||
| 020 |
_a4431560394 _q(electronic bk.) |
||
| 020 |
_a9784431560395 _q(electronic bk.) |
||
| 020 | _z4431560378 | ||
| 020 |
_z9784431560371 _q(print) |
||
| 035 |
_a(OCoLC)957557877 _z(OCoLC)957617615 _z(OCoLC)957739376 |
||
| 040 |
_aN$T _cN$T _dGW5XE _dIDEBK _dYDX _dEBLCP _dN$T _dCASUM _dOCLCO _dOCLCA _dMERER _dOCLCO _dUAB _dOCLCO _dIOG _dESU _dZ5A _dOCLCO _dJBG _dIAD _dICW _dICN _dOTZ _dOCLCQ _dOCLCO _dU3W _dOCLCO _dOCLCA _dES-MaUEC _bspa |
||
| 050 | 4 |
_aRJ406.M83 _b2017 EB |
|
| 245 | 0 | 0 |
_aKawasaki disease : _bcurrent understanding of the mechanism and evidence-based treatment _cBen Tsutomu Saji, Jane W. Newburger, Jane C. Burns, Masato Takahashi, editors. |
| 264 | 1 |
_aJapan _bSpringer _c[2016]. |
|
| 264 | 4 | _c2017 | |
| 300 |
_a1 recurso en línea (xix, 552 páginas) _bilustraciones (algunas a color) |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 500 | _aSpringerLink | ||
| 504 | _aIncluye referencias bibliográficas e índice | ||
| 505 | 0 | _aForeword; Preface; References; Contents; Part I: Basic Research; The History of Kawasaki Disease: A Personal Perspective; Introduction; The Era of Clinical Description and Pathologic Recognition: 1960-1984; Back to the Future: 1871-1984 and Other Riddles of KD; The Era of Enhanced Discovery and International Collaboration: 1984-2015; References; Histopathology of Coronary Arteritis in Acute Kawasaki Disease and Murine Systemic Vasculitis Induced by Candida Albicans Cell...; Introduction; Histopathological Characteristics of Coronary Arteritis in Acute KD | |
| 505 | 8 | _aAdvances in TreatmentAdvances in Genetics; Advances in Biomarkers and Diagnostic Tests; Advances in Understanding Long-Term Outcomes; References; Part II: Epidemiology; Epidemiologic Perspectives; Historical Perspective; KD Surveillance: Moving Forward; KD Surveillance: Prescription for the Future; References; Update on Nationwide Surveys and Epidemiologic Characteristics of Kawasaki Disease in Japan; Introduction; Methods of the Nationwide Surveys; Results of Nationwide Surveys; What We Have Learned from the Descriptive Epidemiology; Conclusions; References | |
| 505 | 8 | _aIdentification of Novel Kawasaki Disease Susceptibility Genes by Genome-Wide Association StudiesIntroduction; History of the Genetic Study of KD; Genomic Studies of KD in the Post-Genomic era; ITPKC; CASP3; FCGR2A; BLK; CD40; HLA class II; Current Understandings and Recognition; Recent Advances; References; Immunological Abnormalities and Use of Biomarkers and Cytokines to Predict the Severity of Kawasaki Disease; Introduction; KD and Hypercytokinemia; Which Cytokines/Biomarkers Best Predict KD Severity?; Conclusions; References; Pathophysiology of Kawasaki Disease; Introduction; History | |
| 505 | 8 | _aThe C. Albicans Cell Wall Polysaccharide-Induced Murine Vasculitis ModelModel Development and Description of the Vasculitis-Inducing Agent; Histopathological Characteristics of C. Albicans Polysaccharide-Induced Murine Vasculitis; Relationship of Mouse Genetic Background to Cytokines and Vasculitis; Response of C. Albicans Polysaccharide-Induced Vasculitis to Treatment; References; Histopathological Characteristics of Noncardiac Organs in Kawasaki Disease; Introduction; Brief Overview of Systemic Vascular Lesions in KD; Histological Changes in Noncardiac Organs in KD; References | |
| 505 | 8 | _aThe Three Linked Pathological Processes of KD VasculopathyRecent Advances in Etiological, Genomic, and Gene Expression Studies; Conclusions; References; Update on Pathogenesis: Lessons Learned from Animal Models of Disease; Introduction; T-Cell Activation and Survival and the Role of Costimulation; Murine Models of KD; References; The Climate-KD Link; References; Kawasaki Disease Shock Syndrome; Introduction; Incidence and Demographics; Mechanisms; Clinical Course and Treatment; Differential Diagnosis; Future Perspectives; References; Future Directions in Kawasaki Disease Research | |
| 588 | 0 | _aOnline resource; title from PDF title page (SpringerLink, viewed September 1, 2016). | |
| 650 | 7 |
_aSistema linfático _xEnfermedades _2embne _9215480 |
|
| 700 | 1 |
_aBurns, Jane C. _eeditor literario |
|
| 700 | 1 |
_aNewburger, Jane W., _eeditor literario |
|
| 700 | 1 |
_aSaji, Ben Tsutomu, _eeditor literario |
|
| 700 | 1 |
_aTakahashi, Masato, _d1933- _eeditor literario |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-4-431-56039-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b02/2018 _dz _e- _zSI |
||